Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 2×

WHO-EORTC classification for cutaneous lymphomas

Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803

Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance

Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067

Reshaping human antibodies for therapy

Riechmann, L., Clark, M., Waldmann, H., & Winter, G. P. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,565

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus

Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R., & Carbone, F. R. (2009) · Nature Immunology · doi:10.1038/ni.1718 · Cited by 1,157

The Vast Majority of CLA+ T Cells Are Resident in Normal Skin

Clark, R. A., Chong, B., Mirchandani, N., Brinster, N. K., Yamanaka, K.-I., Dowgiert, R. K., & Kupper, T. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4431 · Cited by 796

Naive and memory T cells show distinct pathways of lymphocyte recirculation.

Mackay, C. R., Marston, W. L., & Dudler, L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.801 · Cited by 787

Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome

Kim, Y. H., Liu, H. L., Mraz‐Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 652

Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

Campbell, J. J., Clark, R. A., Watanabe, R., & Kupper, T. S. (2010) · Blood · doi:10.1182/blood-2009-11-251926 · Cited by 519

The window of therapeutic opportunity in multiple sclerosis

Coles, A. J., Cox, A., Page, E. L., Jones, J., Trip, S. A., Deans, J., Seaman, S. R., Miller, D. H., Hale, G., Waldmann, H., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506

The Yin and Yang dualistic features of autophagy in thermal burn wound healing

Totan, A., Greabu, M., Stănescu-Spînu, I.-I., Imre, M. M., Spînu, T. C., Miricescu, D., Ilinca, R., Coculescu, E. C., Bădoiu, S. C., Coculescu, B.-I., et al. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221125090 · Cited by 18

Decoding Tissue-Residency: Programming and Potential of Frontline Memory T CellsPreprint

Park, S. L., & Mackay, L. K. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037960 · Cited by 21

Research progress on intestinal tissue‐resident memory T cells in inflammatory bowel disease

Chen, K., Gu, X., Yang, S., Tao, R., Fan, M., Bao, W., & Wang, X. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13332 · Cited by 19

CD8 T cell memory: it takes all kinds

Hamilton, S. E., & Jameson, S. C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00353 · Cited by 20

Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome

Janiga, J., Kentley, J., Nabhan, C., & Abdulla, F. R. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1347650 · Cited by 17

Resident memory CD4 + T lymphocytes mobilize from bone marrow to contribute to a systemic secondary immune reaction

Cendón, C., Du, W., Durek, P., Liu, Y., Alexander, T., Serene, L. G., Yang, X., Gasparoni, G., Salhab, A., Nordström, K. J. V., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202149726 · Cited by 18

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives

Bobrowicz, M., Zagożdżon, R., Domagała, J., Vasconcelos‐Berg, R., Guenova, E., & Winiarska, M. (2019) · Cancers · doi:10.3390/cancers11101420 · Cited by 17

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?

Abdeljaoued, S., Arfa, S., Kroemer, M., Khelil, M. B., Vienot, A., Heyd, B., Loyon, R., Doussot, A., & Borg, C. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003472 · Cited by 17

Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes

Chennareddy, S., Rindler, K., Ruggiero, J. R., Alkon, N., Cohenour, E. R., Tran, S., Weninger, W., Griss, J., Jonak, C., & Brunner, P. M. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae313 · Cited by 16

Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects

Kousin‐Ezewu, O., & Coles, A. J. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313479137 · Cited by 16

Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines

Andrique, L., Poglio, S., Prochazkova‐Carlotti, M., Kadin, M. E., Giese, A., Idrissi, Y., Beylot-Barry, M., Merlio, J., & Chevret, E. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.012 · Cited by 16

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

van der Weyden, C., Bagot, M., Neeson, P. J., Darcy, P. K., & Prince, H. M. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1498081 · Cited by 16

Mycosis fungoides: A clinicopathological study of 60 cases from a tertiary care center

Fatima, S., Siddiqui, S., Tariq, M. U., Ishtiaque, H., Idrees, R., Ahmed, Z. A., & Ahmed, A. (2020) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_602_18 · Cited by 16

The continuing evolution of targeted therapy for inflammatory skin disease

Schlapbach, C., & Navarini, A. A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0524-2 · Cited by 16

Homeostasis and Durability of T-Cell Memory—The Resting and the Restless T-Cell Memory

Radbruch, A., McGrath, M. A., Siracusa, F., Hoffmann, U., Sercan-Alp, Ö., Hutloff, A., Tokoyoda, K., Chang, H.-D., & Dong, J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a038083 · Cited by 16

Rapid Isolation of Functional ex vivo Human Skin Tissue-Resident Memory T Lymphocytes

Du, W., Lenz, D., Köhler, R., Zhang, E., Cendon, C., Li, J., Massoud, M., Wachtlin, J., Bodo, J., Hauser, A. E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624013 · Cited by 15

CCR8 is a new therapeutic target in cutaneous T-cell lymphomas

Giustiniani, J., Dobos, G., Moins‐Teisserenc, H., Eustaquio, T., Battistella, M., Ortonne, N., Ram‐Wolff, C., Bouaziz, J., Marie‐Cardine, A., Mourah, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006512 · Cited by 15

Identification of skin immune cells in non-human primates

Adam, L., Rosenbaum, P., Cosma, A., Grand, R. L., & Martinon, F. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.07.010 · Cited by 15

Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem

Larocca, C. A., Kupper, T. S., & LeBoeuf, N. R. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2742 · Cited by 15

Everything in its right place

Buggert, M., Japp, A. S., & Betts, M. R. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000523 · Cited by 15

Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome

Martinez, X. U., Raimondo, C. D., Abdulla, F. R., Zain, J. M., Rosen, S. T., & Querfeld, C. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.06.004 · Cited by 14

Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?

Virmani, P., Hwang, S., Hastings, J. G., Haverkos, B. M., Kohnken, R. A., Gru, A. A., Mishra, A., Fabbro, S. K., Horwitz, S. M., & Porcu, P. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2017.1270201 · Cited by 14

Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome

Querfeld, C., Zain, J. M., & Rosen, S. T. (2018) · Cancer treatment and research · doi:10.1007/978-3-319-99716-2_11 · Cited by 14

Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma

Nakai, S., Kiyohara, E., & Watanabe, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312933 · Cited by 13

Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract

MacLean, F., Tsegaye, A. T., Graham, J. B., Swarts, J. L., Vick, S. C., Potchen, N. B., Talavera, I. C., Warrier, L., Dubrulle, J., Schroeder, L. K., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184609 · Cited by 14

Immune correlates of melanoma survival in adoptive cell therapy

Fermin, A., Sieling, P. A., & Lee, D. J. (2013) · OncoImmunology · doi:10.4161/onci.22889 · Cited by 13

Epigenetics and tissue immunity—Translating environmental cues into functional adaptations*

Tuong, Z. K., Stewart, B. J., Guo, S. A., & Clatworthy, M. R. (2021) · Immunological Reviews · doi:10.1111/imr.13036 · Cited by 13

Alemtuzumab for multiple sclerosis: the new concept of immunomodulation

Gallo, P., Centonze, D., & Marrosu, M. G. (2017) · Multiple Sclerosis and Demyelinating Disorders · doi:10.1186/s40893-017-0024-4 · Cited by 13

Sustained accumulation of antigen‐presenting cells after infection promotes local T‐cell immunity

Collins, N., Hochheiser, K., Carbone, F. R., & Gebhardt, T. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.60 · Cited by 12

Can Patrolling Liver-Resident T Cells Control Human Malaria Parasite Development?

Walk, J., Stok, J. E., & Sauerwein, R. W. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.002 · Cited by 12

Tissue‐resident regulatory T cells accumulate at human barrier lymphoid organs

Hewavisenti, R., Ferguson, A. L., Gasparini, G., Ohashi, T., Braun, A., Watkins, T. S., Miles, J. J., Elliott, M., Sierro, F., Feng, C. G., et al. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12481 · Cited by 12

The molecular and phenotypic makeup of fetal human skin T lymphocytes

Reitermaier, R., Ayub, T., Staller, J., Kienzl, P., Fortelny, N., Vieyra-Garcia, P. A., Worda, C., Fiala, C., Staud, C. J., Eppel, W., et al. (2021) · Development · doi:10.1242/dev.199781 · Cited by 12

Human T cell immune surveillance: Phenotypic, functional and migratory heterogeneity for tailored immune responses

Zielinski, C. E. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.08.001 · Cited by 13

Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome

Prince, H. M., & Querfeld, C. (2018) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2018.07.007 · Cited by 12

Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome

Rasmussen, T. A., McMahon, J. H., Chang, J. J., Symons, J., Roche, M., Dantanarayana, A., Okoye, A. A., Hiener, B. M., Palmer, S., Lee, W. S., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001540 · Cited by 13

Cutaneous immune‐related adverse events from immune checkpoint inhibitor therapy: Moving beyond “maculopapular rash”

Allais, B. S., Fay, C. J., Kim, D. Y., Semenov, Y. R., & LeBoeuf, N. R. (2023) · Immunological Reviews · doi:10.1111/imr.13257 · Cited by 11

IL-4 impairs the formation of skin-resident memory CD8+ T cells

Mora‐Buch, R., Lake, M. E., Sama, A., Chasse, A. Y., Akbaba, H., Mani, V., & Bromley, S. K. (2025) · Nature Immunology · doi:10.1038/s41590-025-02207-6 · Cited by 12

Histopathologic spectrum of hypersensitivity reactions associated with anti‐ CD52 therapy (alemtuzumab)

Clark, S. L., Tse, J. Y., Fisher, D. C., LeBeouf, N. R., Murphy, G. F., Kupper, T. S., Clark, R. A., & Lian, C. G. (2016) · Journal of Cutaneous Pathology · doi:10.1111/cup.12800 · Cited by 11

Human Tissue-Resident Memory T Cells in the Maternal–Fetal Interface. Lost Soldiers or Special Forces?

DeJong, C. S., Maurice, N. J., McCartney, S. A., & Prlic, M. (2020) · Cells · doi:10.3390/cells9122699 · Cited by 11

Update on Epidemiology of Cutaneous T-Cell Lymphoma

Samimi, S. S., Rook, A. H., & Kim, E. J. (2013) · Current Dermatology Reports · doi:10.1007/s13671-012-0038-2 · Cited by 10

Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma

Kume, M., Kiyohara, E., Matsumura, Y., Koguchi‐Yoshioka, H., Tanemura, A., Hanaoka, Y., Taminato, M., Tashima, H., Tomita, K., Kubo, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651048 · Cited by 10

Novel therapeutic approaches for cutaneous T cell lymphomas

Pavlidis, A., Piperi, C., & Papadavid, E. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1919085 · Cited by 10

Is Cutaneous T-Cell Lymphoma Caused by Ultraviolet Radiation? A Comparison of UV Mutational Signatures in Malignant Melanoma and Mycosis Fungoides

Gniadecki, R., O’Keefe, S. L., Hennessey, D., & Iyer, A. (2023) · Cells · doi:10.3390/cells12121616 · Cited by 11

Targeted multi-omic analysis of human skin tissue identifies alterations of conventional and unconventional T cells associated with burn injury

Labuz, D., Lewis, G. M., Fleming, I. D., Thompson, C. M., Zhai, Y., Firpo, M. A., & Leung, D. T. (2023) · eLife · doi:10.7554/elife.82626 · Cited by 9

Harnessing liver-resident memory T cells for protection against malaria

Fernandez‐Ruiz, D., de Menezes, M. N., Holz, L. E., Ghilas, S., Heath, W. R., & Beattie, L. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1881485 · Cited by 9

Possible Plasticity of Cytotoxic Resident Memory T Cells in Fixed Drug Eruption

Matsumura, Y., Watanabe, R., Koguchi‐Yoshioka, H., Kume, M., Nakai, S., Furuta, J., Azukizawa, H., Ishitsuka, Y., Tanemura, A., Taminato, M., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.11.022 · Cited by 8

Spatial organization of tissue-resident memory T cells

Burn, T. N., & Mackay, L. K. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.009 · Cited by 14

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics

Peiffer, L., Gambichler, T., Buus, T. B., Horny, K., Gravemeyer, J., Furtmann, F., Spassova, I., Kubat, L., Susok, L., Stranzenbach, R., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1090592 · Cited by 7

Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T‐cell lymphoma

Vandersee, S., Humme, D., Terhorst‐Molawi, D., Almohamad, A., Möbs, M., & Beyer, M. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12549 · Cited by 7

Alemtuzumab‐induced Alopecia areata – a case report and systematic literature review of adverse events associated with Alemtuzumab

Dikeoulia, E., Neufeld, M., Pawlitzki, M., & Böhm, M. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14448 · Cited by 7

Does molecular scarring in psoriasis exist? A review of the literature

Kasprowicz‐Furmańczyk, M., Narbutt, J., Borzęcki, A., & Owczarczyk-Saczonek, A. B. (2023) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.129322 · Cited by 7

Novel immunosuppressive strategies for composite tissue allografts

Gupta, A., Kumer, S. C., & Kaplan, B. E. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000135 · Cited by 7

Monoclonal antibodies against cutaneous T-cell lymphomas

Alaibac, M. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1369951 · Cited by 7

Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre

de Masson, A., Lazaridou, I., Moins‐Teisserenc, H., Ram‐Wolff, C., Giustiniani, J., Bagot, M., Battistella, M., & Bensussan, A. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106871 · Cited by 6

Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment—A Cross-Sectional Study

Cunha, D., Neves, M., Silva, D., Silvestre, A. R., Borralho, P., Arrobas, F., Ribot, J. C., Ferreira, F., Moita, L. F., Soares‐de‐Almeida, L., et al. (2024) · Cells · doi:10.3390/cells13110964 · Cited by 7

Pathology of T-Cell Lymphomas: Diagnosis and Biomarker Discovery

Gru, A. A. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-13150-4_3 · Cited by 6

Cellular Composition of Lymph

Platt, A. M., & Randolph, G. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3235-7_4 · Cited by 7

Less Can Be More: The Impact of Chemotherapy on Cutaneous T-Cell Lymphomas

Dummer, R., Rozati, S., Guenova, E., & Cozzio, A. (2013) · Future Oncology · doi:10.2217/fon.13.87 · Cited by 6

Targeted therapies for cutaneous T-cell lymphomas

Kaplan, J. B., Guitart, J., & Giles, F. J. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.942279 · Cited by 6

Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab

Saulīte, I., Guenova, E., & Hoetzenecker, W. (2017) · Current problems in dermatology · doi:10.1159/000478079 · Cited by 6

Alemtuzumab‐induced halo naevus‐like hypopigmentation – new insights into secondary skin autoimmunity in response to an immune cell‐depleting antibody

Böhm, M., Kemp, E. H., Metze, D., Muresan, A. M., Neufeld, M., Luiten, R. M., & Ruck, T. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16781 · Cited by 6

Mycosis fungoides und Sézary‐Syndrom

Jonak, C., Tittes, J., Brunner, P. M., & Guenova, E. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14610_g · Cited by 6

(Not) Home alone: Antigen presenting cell – T Cell communication in barrier tissues

Neuwirth, T., Knapp, K., & Stary, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984356 · Cited by 6

Alemtuzumab treatment for Sézary syndrome: A single-center experience

Novelli, S., García‐Muret, P., Sierra, J., & Briones, J. (2015) · Journal of Dermatological Treatment · doi:10.3109/09546634.2015.1086479 · Cited by 6

Defining T Cell Tissue Residency in Humans: Implications for HIV Pathogenesis and Vaccine Design

Shacklett, B. L., Ferre, A. L., & Kiniry, B. E. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00481-7 · Cited by 6

New nonchemotherapy treatment options for cutaneous T-cell lymphomas

Xu, S., & Foss, F. M. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1882859 · Cited by 6

Modulation of CD4+ T Helper Cell Memory Responses in the Human Skin

Padovan, E. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000477728 · Cited by 6

Cytokine and metabolite networks shape T cell residency and functionality at the term human maternal-fetal interface

Maurice, N. J., Erickson, J. R., DeJong, C. S., Mair, F., Taber, A. K., Frutoso, M., Islas, L., Vigil, A.-L. B. G., Lawler, R. L., McElrath, M. J., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf093 · Cited by 5

Resident memory T cells in mouse and human

Watanabe, R. (2016) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.39.505 · Cited by 5

Management of the Cutaneous Peripheral T-Cell Lymphomas

Choi, M. Y., & Lechowicz, M. J. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31826c57f1 · Cited by 5

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection

Hullegie-Peelen, D. M., van der Zwan, M., Groningen, M. C. C., Mustafa, D. A. M., Baart, S. J., Reinders, M. E. J., Baan, C. C., & Hesselink, D. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2566 · Cited by 5

Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells

Shang, Y., He, Y., Zhang, X., He, W., Hua, H., Feng, Y., Zhou, X., Li, Y., Zhong, W., Wu, G. S., et al. (2025) · Immunology · doi:10.1111/imm.13924 · Cited by 5

Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model

Xia, J., Hochgerner, M., Wei, Q., Zhong, X., & Wang, J. (2025) · Barrier Immunity · doi:10.1002/dni2.70002 · Cited by 4

Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers

Calvão, J., Iselin, C., Wasmayr, J., Furtmüller, C., Zeng, Z., Vadivel, C. K., Gluud, M., Bataiosu-Zimmer, E., Buus, T. B., Ødum, N., et al. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.03.035 · Cited by 4

Mycosis fungoides presenting at the site of a transdermal estradiol patch

Alloo, A., DeSimone, J., & Kupper, T. S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.02.035 · Cited by 4

Components of the Immune System

Sun, H., Sun, R., & Tian, Z. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_1 · Cited by 4

Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy

Xiao, Y., Yang, Q., & Sun, Z. (2025) · Cancer Medicine · doi:10.1002/cam4.71429 · Cited by 4

Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence

Zdanowska, N., Machoń, N. J., Frączek, A., Kasprowicz‐Furmańczyk, M., Czerwińśka, J., & Owczarczyk-Saczonek, A. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1849265 · Cited by 3

Single-cell differentiation trajectories define early stages of a human cutaneous T-cell lymphoma

Cerapio, J., Perrier, M., Pont, F., Laurent, C., Bertani, S., & Fournié, J. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00044 · Cited by 3

Structure of the Skin and Cutaneous Immunology

Plager, D. A., Bieber, T. R. M., & Pittelkow, M. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00034-6 · Cited by 4

Differences in Immune phenotype in decidual tissue from multigravid women compared to primigravid women

Laskewitz, A., Kieffer, T. E. C., van Benthem, K. L., Erwich, J. J., Faas, M. M., & Prins, J. R. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13658 · Cited by 3

Harnessing the immune system in the treatment of cutaneous T cell lymphomas

Fay, C. J., Awh, K. C., LeBoeuf, N. R., & Larocca, C. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1071171 · Cited by 3

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence

Varco-Merth, B. D., Chaunzwa, M., Duell, D. M., Marenco, A., Goodwin, W., Dannay, R., Nekorchuk, M. D., Shao, D., Busman‐Sahay, K., Fennessey, C. M., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012496 · Cited by 3

Tissue-Resident CD8+ T Cells as Mediators of Protective Immunity in Breast Milk Transmission of Human Cytomegalovirus

Legg, S. B., Moylan, D. C., Kamau, N., Latting, M., Devdhara, D., Pati, S. K., Crossman, D. K., Boppana, S. B., Kutsch, O., & Sabbaj, S. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae618 · Cited by 3

Personal reflections on 25 years of immunodermatology

Kupper, T. S. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13366 · Cited by 3

Labeling and tracking of immune cells in ex vivo human skin

Dijkgraaf, F. E., Toebes, M., Hoogenboezem, M., Mertz, M., Vredevoogd, D. W., Matos, T. R., Teunissen, M. B. M., Luiten, R. M., & Schumacher, T. N. (2020) · Nature Protocols · doi:10.1038/s41596-020-00435-8 · Cited by 3

Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report

McKenzie, M., Bissell, B. D., Disselkamp, M., Hildebrandt, G. C., & Cox, J. N. (2019) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155219865313 · Cited by 3

Immunology of the Skin

Richmond, J. M., & Harris, J. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.19007-1 · Cited by 3

Psoriasis, Cutaneous Lupus Erithematosus and Immunobiology of the Skin

Meglio, P. D., & Conrad, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.15008-8 · Cited by 4

Immunobiology and treatment of cutaneous T-cell lymphoma

Goel, R. R., & Rook, A. H. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2326035 · Cited by 2

Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma

Chinas, N. A., Kaliampou, S., & Nikolaou, V. A. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01646-6 · Cited by 2

Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature

del Alcázar, E., Tuneu-Valls, A., López-Pestaña, A., & Vidal-Manceñido, M. J. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2015.06.005 · Cited by 2

Cutaneous Adverse Events Under New Clinical Therapies: Drug-Induced Vitiligo-Like Depigmentation

Ma, J., Chen, K., & Luan, C. (2023) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000296 · Cited by 2

Preliminary analysis of spatial-temporal homogeneity and heterogeneity of TCR β chain CDR3 repertoires in BALB/c mice.

Li, Y., Ma, L., Dong, X., Pan, Y., Shi, B., He, X., Zhang, T., Sun, S., & Yao, X. (2019) · Europe PMC (PubMed Central) · Cited by 2

Targeted Approaches to T-Cell Lymphoma

Harrop, S., Abeyakoon, C., van der Weyden, C., & Prince, H. M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060481 · Cited by 2

Cutaneous T-Cell Lymphoma

Stephen, S., Kim, E. J., Introcaso, C. E., Richardson, S. K., & Rook, A. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_41 · Cited by 2

Analysis of Skin Immune Cells in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Clatch, A., Trubiano, J. A., Holmes, N. E., Chua, K., Luca, J. D., Chan, S., Godsell, J., Andrews, E., Aung, A. K., Zubrinich, C., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.08.027 · Cited by 2

Tratamiento del síndrome de Sézary con alemtuzumab: serie de 5 casos y revisión de la literatura

del Alcázar, E., Tuneu-Valls, A., López-Pestaña, A., & Vidal-Manceñido, M. J. (2015) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2015.02.008 · Cited by 2

Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides

Kwong, Y. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1869-z · Cited by 2

Biomédicaments dans le traitement des lymphomes T cutanés

de Masson, A., Ram‐Wolff, C., & Bagot, M. (2021) · Annales de Dermatologie et de Vénéréologie - FMC · doi:10.1016/j.fander.2020.05.007 · Cited by 2

Infection risk not increased with alemtuzumab

Furlow, B. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70036-0

Low-Dose Alemtuzumab Is Uniquely Effective in Refractory Leukemic Cutaneous T Cell Lymphoma (L-CTCL).

Fisher, D. C., Tawa, M. C., Walsh, M., Clark, R. A., & Kupper, T. S. (2009) · Blood · doi:10.1182/blood.v114.22.3748.3748 · Cited by 15

612 Treg depletion syndrome: Skin inflammation unleashed by ADCC depleting biologics

Gray, L., Larocca, C., Merola, J., Kupper, T. S., Teague, J. E., Gehad, A. E., Gerard, N., Zhan, Q., LeBoeuf, N., & Clark, R. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.03.619

Acute cutaneous T-cell lymphoma transformation during treatment with alemtuzumab

Faguer, S., Launay, F., Ysebaert, L., Mailhol, C., Estines-Chartier, O., Lamant, L., & Paul, C. F. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08130.x · Cited by 16

Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphoma

Larocca, C. A., Bui, A. N., O’Malley, J. T., Giobbie‐Hurder, A., Tawa, M. C., Teague, J. E., Clark, R. A., Cutler, C. S., Jacobsen, E. D., Fisher, D. C., et al. (2025) · Blood Cancer Journal · doi:10.1038/s41408-025-01237-5 · Cited by 1